MLH1、MSH2基因在散发性左、右半结肠癌中的表达差异及对临床特征的影响
PDF下载 (7109)武 凌,余秀国,杭 晨,夏洪兵,贺侠峰,施益九.MLH1、MSH2基因在散发性左、右半结肠癌中的表达差异及对临床特征的影响[J].宁波大学学报(理工版),2020,33(4):103-108.DOI:
WU Ling,YU Xiuguo,HANG Chen,XIA Hongbing,HE Xiafeng,SHI Yijiu.Expression difference of MLH1 and MSH2 genes in sporadic left and right colon cancer and their relationship with clinical characteristics[J].Journal of Ningbo University(Natural Science & Engineering Edition),2020,33(4):103-108.DOI:
| Title: | Expression difference of MLH1 and MSH2 genes in sporadic left and right colon cancer and their relationship with clinical characteristics |
| 作者: | 武 凌, 余秀国, 杭 晨, 夏洪兵, 贺侠峰, 施益九 |
| Author(s): | WU Ling, YU Xiuguo, HANG Chen, XIA Hongbing, HE Xiafeng, SHI Yijiu |
| 关键词: | 结直肠癌; 错配修复基因; 免疫组织化学; 病理 |
| Keywords: | MLH1; MSH2; colorectal cancer; mismatched repair genes; immuno histochemistry; pathology |
| 分类号: | R735.3+5 |
| 文献标识码: | A |
| 摘要: | 探讨错配修复基因MLH1、MSH2在散发性左、右半结肠患者中的表达差异, 并分析这种差异与结直肠癌临床病理特征的相关性. 收集2015年12月至2018年12月期间, 在宁波市第一医院就诊的133例结直肠癌患者的病例资料, 分析左、右半结肠癌中MLH1、MSH2基因的表达差异, 以及这种差异与结直肠癌临床病理特征的相关性. 结果表明, 在结直肠癌病例中, MLH1、MSH2的表达缺失率与肿瘤的发病部位和分化程度有关(P＜0.05), 右半结肠癌的病例与总体样本表现更相近. 在散发性结直肠癌中, MLH1、MSH2的表达缺失率方面, 右半结肠癌高于左半结肠. 在右半结肠癌病例中, MLH1、MSH2的表达缺失患者相对发病年龄早, 分化程度低, 不容易发生神经浸润; 而在左半结肠癌MLH1、MSH2的表达缺失病例中, 无明显相关表现. |
| Abstract: | The current study was aimed to investigate the expression differences of mismatch repair genes MLH1 and MSH2 in the left and right hemispheres of the colon in patients with sporadic colorectal cancer, followed by the analysis of the relationship between these differences and the clinic pathological characteristics of colorectal cancer. From December 2015 to December 2018, 133 patients with colorectal cancer treated in the Ningbo No.1 hospital were collected for medical records. The differences of MLH1 and MSH2 gene expressions in left and right colon cancer were statistically analyzed, and the relationship between MLH1 and MSH2 expression loss and clinic opathological characteristics of colorectal cancer was also analyzed. The results demonstrated that, in the cases of colorectal cancer, the loss of MLH1 and MSH2 expression is related to the tumor location, the degree of differentiation of tumor tissue (P<0.05). The cases of right colon cancer were more similar to the general sample. It is concluded that the expression loss of MLH1 and MSH2 in the right colon cancer was significantly higher than that in the left colon cancer. In the case of right colon cancer, the patients with MLH1 and MSH2 expression deficiency were relatively early in onset age, low in differentiation degree, and not prone to nerve infiltration. However, there was no significant correlation between MLH1 and MSH2 expression in the left colon cancer. |
| 参考文献 /References: | [1] Ferlay J, Soerjomataram I, Ervik M, et al. Globocan 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no.11[C]. International Agency for Research on Cancer, Lyon, France, 2013. [2] Arnold M, Sierra M S, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut, 2017, 66(4):683-691. [3] 顾晋, 汪建平. 中国结直肠癌诊疗规范(2017年版)[J]. 中华临床医师杂志(电子版), 2018, 12(1):3-23. [4] Mirkin S M. Expandable DNA repeats and human disease[J]. Nature, 2007, 447(7147):932-940. [5] Iyer R R, Pluciennik A, Burdett V, et al. DNA mismatch repair: Functions and mechanisms[J]. Chemical Reviews, 2006, 106(2):302-320. [6] Nystr?m-Lahti M, Parsons R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage[J]. American Journal of Human Genetics, 1994, 55(4):659-665. [7] Peltom?ki P. Deficient DNA mismatch repair: A common etiologic factor for colon cancer[J]. Human Molecular Genetics, 2001, 10(7):735-740. [8] 王玉, 王水明, 方明治, 等. MLH1/MSH2在散发性结直肠癌中的表达及其与预后的关系[J]. 肿瘤, 2018, 38(5):437-445. [9] Sieber O M, Heinimann K, Tomlinson I P M. Genomic instability - the engine of tumorigenesis?[J]. Nature Reviews Cancer, 2003, 3(9):701-708. [10] Pancione M, Remo A, Colantuoni V. Genetic and epigenetic events generate multiple pathways in colorectal cancer progression[J]. Pathology Research International, 2012, 2012:1-11. [11] Slomka M, Stasikowska O, Wagrowska-Danilewicz M, et al. Diagnostic and prognostic values of repair protein hMLH1, hMSH2 and protein CD34 immunoexpression in sporadic colorectal cancer[J]. Polski Merkuriusz Lekarski, 2010, 29(174):351-356. [12] 王朝夫, 周晓燕, 张太明, 等. MLH1、MSH2基因mRNA突变分析与遗传性非息肉性结直肠癌的基因诊断[J]. 中华医学遗传学杂志, 2006, 23(1):32-36. [13] Bufill J A. Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location[J]. Annals of Internal Medicine, 1990, 113(10):779-788. [14] Macfarlane G T, Gibson G R, Cummings J H. Comparison of fermentation reactions in different regions of the human colon[J]. Journal of Applied Bacteriology, 1992, 72(1):57-64. [15] Povey A C, Hall C N, Badawi A F, et al. Elevated levels of the pro-carcinogenic adduct, O6-methylguanine, in normal DNA from the cancer prone regions of the large bowel[J]. Gut, 2000, 47(3):362-365. [16] 徐晋珩, 胡月明, 崔永兴, 等. 淋巴结转移性结直肠癌中MLH1与MSH2基因的表达水平及其临床意义[J]. 中国临床研究, 2018, 31(1):22-27. [17] Carethers J M, Chauhan D P, Fink D, et al. Mismatch repair proficiency and in vitro response to 5-fluorouracil[J]. Gastroenterology, 1999, 117(1):123-131. [18] Bertagnolli M M, Niedzwiecki D, Compton C C, et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin instage III colon cancer: Cancer and leukemia group B protocol 89803[J]. Journal of Clinical Oncology, 2009, 27(11):1814-1821. |
| 备注/Memo: | 收稿日期: 2020－04－04. 宁波大学学报（理工版）网址: http://journallg.nbu.edu.cn/基金项目: 宁波市医学科技计划项目（2017A55）.第一作者: 武凌（1985－）, 男, 浙江淳安人, 主治医师, 主要研究方向: 胃肠外科. E-mail: wuling198544@163.com*通信作者: 施益九（1975－）, 男, 浙江慈溪人, 主任医师, 主要研究方向: 胃肠肿瘤. E-mail: surgeonshi@163.com 宁波大学学报（理工版）网址：http://journallg.nbu.edu.cn/ |
